3-hydroxyanthranilic acid is independently associated with monocyte chemoattractant protein-1 (CCL2) and macrophage inflammatory protein-1β (CCL4) in patients with chronic kidney disease

Clinical Biochemistry

Volumn 43, Issue 13-14, 2010, Pages 1101-1106

  Pawlak, Krystyna ^a   Kowalewska, Anna ^a   Mysliwiec, Michal ^a   Pawlak, Dariusz ^a,b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

3 hydrohyanthranilic acid; Anthranilic acid; CC chemokines; Chronic renal disease

Indexed keywords

3 HYDROXYANTHRANILIC ACID; C REACTIVE PROTEIN; CHEMOKINE; COPPER ZINC SUPEROXIDE DISMUTASE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MALE; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL;

3-HYDROXYANTHRANILIC ACID; ADULT; AGED; ATHEROSCLEROSIS; CHEMOKINE CCL2; CHEMOKINE CCL4; CHEMOKINES, CC; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; KYNURENINE; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC;

EID: 77956180411     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.06.008     Document Type: Article

References (27)

1. Stenvinkel P., Heimburger O., Paultre F., et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999, 55:1899-1911.
2. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354:610-621.
3. Nelken N.A., Coughlin S.R., Gordon D., Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991, 88:1121-1127.
4. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., et al. Expression of monocyte chemoattractant protein-1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991, 88:5252-5256.
5. Wilcox J.N., Nelken N.A., Coughlin S.R., Gordon D., Schall T.J. Local expression of inflammatory cytokines in human atherosclerotic plaques. J Atheroscler Thromb 1994, 1:S3-S10.
6. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 1993, 45:309-379.
7. Chiarugi A., Carpenedo R., Moroni F. Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase. J Neurochem 1996, 67:692-698.
8. Goldstein L.E., Leopold M.C., Huang X.D., et al. 3-hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction. Biochemistry 2000, 39:7266-7275.
9. Weiss G., Diez-Ruiz A., Murr C., Theurl I., Fuchs D. Tryptophan metabolites as scavengers of reactive oxygen and chlorine species. Pteridines 2002, 13:140-144.
10. Schroecksnadel K., Frick B., Winkler C., Fusch D. Crucial role of interferon-γ and stimulated macrophages in cardiovascular disease. Curr Vasc Pharmacol 2006, 4:205-213.
11. Pawlak K., Naumnik B., Brzósko S., Pawlak D., Myśliwiec M. Oxidative stress-a link between endothelial injury, coagulation activation and atherosclerosis in haemodialysis patients. Am J Nephrol 2004, 24:154-161.
12. Pawlak K., Pawlak D., Brzosko S., Mysliwiec M. Carotid atherosclerosis is associated with enhanced β-chemokine levels in patients on continuous ambulatory peritoneal dialysis. Atherosclerosis 2006, 186:146-151.
13. Pawlak K., Pawlak D., Mysliwiec M. Inflammation but not oxidative stress is associated with β-chemokine levels and prevalence of cardiovascular disease in uraemic patients. Cytokine 2006, 35:258-262.
14. Pawlak K., Domaniewski T., Mysliwiec M., Pawlak D. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. Atherosclerosis 2009, 204:309-314.
15. Pawlak K., Brzosko S., Mysliwiec M., Pawlak D. Kynurenine, quinolinic acid-the new factors linked to carotid atherosclerosis in patients with end-stage renal disease. Atherosclerosis 2009, 204:561-566.
16. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S76-S92.
17. Herve C., Beyne H., Jamault H., Delacoux E. Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorometric detection. J Chromatogr 1996, 675:157-161.
18. Jacobson S.F., Egberg N., Hylander B., Lundahl J. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol 2002, 22:42-47.
19. Stinghen A.E., Goncalves S.M., Martines E.G., et al. Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease. Nephron Clin Pract 2009, 111:c117-c126.
20. Schefold J.C., Zeden J.-P., Fotopuolou C., et al. Increased indoleamine 2, 3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol Dial Transplant 2009, 24:1901-1908.
21. Pasceri V., Chang J.B.S., Willerson J.T., Yeh E.T.H. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001, 103:2531-2534.
22. 2 integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1α (MIP-1α) and MIP-1β production by primary human monocytes through a pathway dependent on nuclear factor- B. Blood 2001, 97:2932-2940.
23. Sharma A.K., Srinivasan B.P. Triple versus glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats. Eur J Pharm Sci 2009, 38:433-444.
24. Giles G.I., Collins C.A., Stone T.W., Jacob C. Electrochemical and in vitro evaluation of the redox properties of kynurenine species. Biochem Biophys Res Commun 2003, 300:719-724.
25. Pae H.-O., Oh G.-S., Lee B.-S., Rim J.-S., Kim Y.-M., Chung H.-T. 3-hydroxyanthranilic acid, one of L-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells. Atherosclerosis 2006, 187:274-284.
26. Peters W., Charo I.F. Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice. Curr Opin Lipidol 2001, 12:175-180.
27. Whitman S.C., Ravisanker P., Elam H., Daugherty A. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. Am J Pathol 2000, 157:1819-1824.